Community vaccination center, Covid-19, Pain, SARS-CoV-2, Self-reported adverse reactions, Severe allergic reactions, Systemic reactions
Biosimilar, Interrupted Time-Series Analysis, Quasi experiment, Infliximab, Consumption, Listed Price, Drug policy, Economics